We only have this paper's title and publication details.
Read it at the sourceCompares therapy-free remission achieved by imatinib and nilotinib, suggesting both treatments are equally effective.
Imatinib and nilotinib are equally successful
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: